New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl…
Voxtur Announces Financial Results Delay for Q2 2025
August 29, 2025 19:10 ET | Source: Voxtur Analytics Corp. TORONTO and…
Morphy Richards Brings “Innovate for Enlightening Progress” to IFA Berlin 2025
BERLIN, Aug. 29, 2025 /PRNewswire/ -- Morphy Richards, a trusted name in…
Hisense Tops Global Large-Screen TV Market, Pioneers Next-Gen RGB-MiniLED Ahead of IFA 2025
QINGDAO, China, Aug. 29, 2025 /PRNewswire/ -- Hisense, a leading brand in…
Hexaware Wins Three Stevie Awards at the 2025 International Business Awards
Honors spotlight growth in North America and modern marketing excellence MUMBAI, India…
Midea Group Reports a Record-Breaking Financial Performance in 2025 H1
FOSHAN, China, Aug. 29, 2025 /PRNewswire/ -- Midea Group has achieved a…
Talentica Announces Agentic AI 2025 Hackathon Winners
PUNE, India, Aug. 29, 2025 /PRNewswire/ -- Talentica Software, an AI-native product engineering…
IBEX Limited to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on September 11, 2025
August 28, 2025 16:30 ET | Source: Ibex Limited WASHINGTON, Aug. 28,…
Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update
All dollar amounts reflected in Canadian dollars unless otherwise stated August 28,…
SANY Reports Strong First Half 2025 Results, Delivering Profitable Growth
Revenue Up 15% to $6.24 Billion; Operating Cash Flow Up 20% to…
